Product
SAR445088
Aliases
SAR445088 (BIVV020), SAR445088 (IV), SAR445088 (SC)
3 clinical trials
3 indications
Indication
Autoimmune Hemolytic AnemiaIndication
Immune Thrombocytopenia (ITP)Clinical trial
An Open-label, Long-term, Safety and Tolerability Study of SAR445088 in Participants With Cold Agglutinin Disease Previously Treated With SAR445088 or Never Treated With SAR445088Status: Active (not recruiting), Estimated PCD: 2026-01-23
Clinical trial
A Phase 2, Multicenter, Open-label, Non-randomized, Proof-of-concept Study Evaluating the Efficacy, Safety, and Tolerability of SAR445088 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Status: Active (not recruiting), Estimated PCD: 2025-08-25
Clinical trial
A Multicenter, Phase 2a, Open-label, Non-randomized Study Evaluating the Efficacy, Safety, and Tolerability of BIVV020 in Adults With Persistent/Chronic Immune Thrombocytopenia (ITP)Status: Completed, Estimated PCD: 2022-02-15